A B S T R A C T Encdothelial cells were cutltured from various different human vessels, including aortas, pulmonarv, ovarian, and umbilical arteries, an(l pulmonary, ovarian, an(l umilbilical veins. The culturedl cells were identifie(d as endothelial cells by the presence of Factor VIII antigeni and antiotenisini I convertinig enzyme (kininlase II). They retainedl these markers for at least five passages in culture, and somle cells had them for seven passages or nmore. Endothelial cells from the various vessels were comiiparedl with respect to their ability to metabolize angiotensins I and II and bradykinin. Cells fromi arteries had three to five timles the angiotenisini I converting enzyme activity as cells from veins. The activity of angiotensinase A (aspartyl ami nopeptidlase) had a similar distribution, andl cells from arteries were conisistenitly more active than cells fromn veins. Cultures of endothelial cells from pulmonary and umbilical vessels formed prostacyclin in responise to mechanical stimulationi. MIedia from cell moniolayers that were subjecte(l to a change of medliumii and gentle agitation inhibited aggregation of humilani platelets. This inhibitory activity was generated within 2-5 mnm, and it was not formed by cells that were treated with indomnethacini or tranylcypromiine. Additioni of prostaglanidin (PG)H2 to indomethacin-treated cells restored the ability to form the inhibitor, but cells treated with tranylcypromine were not responsive to PGH2. In experiments where [ 14C ]arachidonic acid was added to the cells before stimulation, the major metabolite identified by thin-layer chromatography was 6-keto PGF1t. Thus, it appears that pulmonary endothelial cells, as well as umbilical cord cells, can form prostacyclin. In experiments comparing the ability of arterial and venous cells to form prostacyclin, arterial cells were more active than venous cells. These studies of cells from various human vessels suggest that the vascular origin ofculturecl endothelial cells determines how they metabolize vasoactive peptides and form prostacyclin.
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INTRODUCTION
The pulmonary vascular endotheliumii is a major site for the metabolismii of bradykinin and angiotensin I .
The aiigiotenlsinl I conivertinig enzymne (EC 3.4.15.1; kininlase II; peptidvl dipeptidlase) is localized on plasmiia membranes of enclothelial cells (1, 2) where it canl activate angiotenisin I and inactivate bradykinin by cleavage of a carboxyl terminial dipeptide fromn these sut)strates (3, 4) .
Anigiotensin I is activate(d in other vascular beds as well (5) (6) (7) , and angiotenisini I conivertinig enzyme has been idlentified by fluorescenit antibodies in endothelium of aorta (8) and( many different organs (2) . Although angiotensin II is not inactivated during passage through the pulmonary circulation (9, 10) , it is readlilv inactivated in other vascular beds (11) .
The cuilture of en(lothelial cells has stimnulated studlies of their morphologic and functional properties. Endothelial cells have been cultured from veins of human umiibilical cords (12) (13) (14) (15) (16) , vena cavae of rabbits (17) , andI large arterial vessels of pigs (18) (19) (20) and cows (21) (22) (23) (24) . Most cultured endothelial cells retain the features of endotheliumii in vivo, including an epithelioid shape an(V Weibel-Palade bodies in the cytoplasm (25) (26) (27) . Factor VIII antigen is associated with cells fromn human veins (12, 15) and with cells from aortas of animials (19, 21, 24) . Angiotensin I convertinig enzyme activity is found in cells from umbilical cord veins (15, 16) and also in aortic endothelial cells from various species (20, 28, 29) . Cultured endothelial cells can transport serotonin (22) and adenine nucleotides (20) , and they can form prostacyclin in response to mechanical or enzymatic stimulation (30) (31) (32) (33) .
The extensive surface provided by pulmonary capillary endothelium could account for the efficiency of the lung in metabolismii ofvasoactive peptides (11) . Alterniatively, the pulmioniary vascular endothelium may have greater enzymatic activities than endothelium in other vascular beds. This study of endothelial cells cultured from different human vessels was made to determine whether the origini of the cell affects its ability to metabolize vasoactive peptides or to form prostacyclin.
Some results were reported previously in abstracts (16, 34 for Factor VIII antigen and tested for enzyme activity between the first and third passage, but a few cultures were tested as late as the seventh passage. Pulmonary arteries and veins were dissected from whole lungs down to the level of the third and fourth branching points. Ovarian vessels were dissected from the ovarian ligament, and all vessels were cleaned free of adhering connective tissues, rinsed in protein-free culture medium, and placed on moist, sterile gauze in a small petri dish. While trypsin (0.125%) was used for some preparations from umbilical (15) or pulmonary (16, 34) vessels, most of the cultures in this study were started from cells detached with 0.25% collagenase. The enzyme was introduced into the vessel lumeni with a polyethylene-tipped syringe, and the endothelial surfaces were gently rubbed together, but the branches and ends of the vessel were not clamped. The specimens were covered with moist gauze and placed in a 370C incubator for 10-15 min. The detached cells were collected by washing the endothelial surfaces with protein-free culture medium. The cells were rinsed into tubes containing 5 ml of medium plus antibiotics and 30% fetal calf serum. They were centrifuged to a pellet, I Abbreviations used in this paper: FITC (37) . Factor VIII antigetn. Factor VIII antigen was identified in initial and passaged cultures of endothelial cells by an indirect fluorescent antibody techniique (12, 39) . Cultures were grown on glass coverslips from freshly isolated cells or from cells detached with trypsin at the time of transfer. They wvere fixed with 2.5% glutaraldehyde for 10 min at room temperature, rinsed with 1% sodium borhydride twice, with phosphatebuffered saline once, and rabbit anti-Factor VIII antigen in a dilution of 1:10 was applied to the surface of the coverslip in a volume of 250 ,ul. The coverslips were incubated at 370C for 30 min in an atmosphere of 5% CO2. They wvere washed well with three rinses of phosphate-bufferedl saline Platelet aggregationi. The inhibition of platelet aggregation by media from enidothelial cell cultures was used as a bioassay for prostacvclin (30, 31 Tli in-lajer r(dioclirot (atogralph l. The production of prostacvclini from arachidonic acid in cultured endlothelial cells was establishecl by the formationi of 6-keto PGF,a (30, 32) . were chromatographedl on a separate plate. Separation of the prostaglancdins was improved by drying each plate and runininig it a second time in the same solvent. At the endl of the second chromatography, the standlard plates were sprayed wvith 3.5% phosphomolvbdic acid to develop the spots correspondling to the prostaglanidinis. The radiolabeledl test plates wvere scanne(d in a Packard chromatograph scainner (Packard Instrumilenit Co., Inc., Dowvners Grove, Ill.) anid the radioactive peaks were comiipared with the spots developed on the stand(lardl plates.
RESULTS
Cell cuilture.s. Endclothelial cells from all of the vessels examiinied had a simiiilar appearanice unider phase microscopy. All cultures startecl froml smiiall cltumllps of cells and(l spread into monolavers within -2-3 vk. Cells fromii adult vessels grew slowly at first and cells (livided only at the edge of each clump. After 10-14 dl in culture, however, cell division was more rapid, anid transferred cells becamiie confluenit within a imiatter of days instead of weeks. Umbilical cord cells grew at a uniformly slow rate in 1)oth initial and transferred cultuires. The appearanice of endothelial cells from pulmonary artery is shown in Fig. 1 in the amount of material in cells from different vessels could be detected by this method. All of the cultures treated with antibody to Factor VIII and then with FITC-labeled anti-gamma globulin developed an intense yellow fluorescence. In contrast, cells treated with saline or with normal rabbit serum and FITC-antibody had only pale green background fluorescence. Fig. 2 shows the labeling of pulmonary and umbilical arterial cells with fluorescent antibody. Factor VIII antigen was present in all cultures examined between the first and fifth passages, and in four out of six cultures examined as late as the seventh passage. In two of the older cultures staining was diminished, and the cultures contained large, fibrillar cells that resembled smooth muscle cells. However, all cultures of pulmonary, umbilical, or ovarian cells that retained their epithelioid shape were positive for Factor VIII antigen.
Enzymatic activities. Angiotensin I converting enzyme (kininase II) activity was present in all cultures of endothelial cells studied. To establish that this marker was retained over the time of the enzymatic studies, three different cultures (one pulmonary vein and two pulmonary artery cultures) were tested at different passages. Fig. 3 shows the activity of the angiotensin I converting enzyme as measured by the hydrolysis of pH]hippuryl glycylglycine. Although the activity was higher in the two arterial cultures than in the venous one, it remained constant for at least five passages. In one arterial culture a decrease in the enzymatic activity between the fifth and seventh passages was associated with a change in the morphology of the cells. These cells became larger and assumed an overlapping, interwoven appearance similar to that of smooth muscle cells. This particular culture was also negative for Factor VIII antigen at the seventh passage.
The activity of angiotensin I converting enzyme in cells from arteries and veins was compared with two different substrates. Only cells in the first four passages were used for the enzyme determinations. With either bradykinin or [H] hippuryl glycylglycine, the activity in cells from arteries was higher than in cells from veins. Fig. 4 shows the activity of angiotensin I converting enzyme measured by hydrolysis of pH]-hippuryl glycylglycine in cells from aorta, pulmonary, ovarian, and umbilical vessels. Table I on a rocker platform inhibited the aggregation of platelets caused by thrombin, ADP, sodium arachidonate, and the endoperoxide analog, U-41669. This inhibitory activity was generated within 2-5 min after the cells were stimulated by a change of medium and agitation, but it was not formed by cultures that were treated with either indomethacin or tranylcypromine (Fig. 5) . The inhibitory activity formed by control (untreated) cultures was lost if the samples were acidified, or if they were heated to 100°C for 2 min.
Scraping the cells with a rubber spatula provided a more vigorous stimulation for prostacyclin formation. Scraping and vigorous agitation on a vortex mixer increased the amount of prostacyclin to more than 50 times that formed by intact cell monolayers. The amount of prostacyclin formed by scraped cells increased still further if the endoperoxide, PGH2, was added just before scraping. Indomethacin and tranylcypromine blocked prostacyclin formation in scraped cells, but addition of PGH2 reversed the inhibition only in indomethacin-treated cells (Table III) . with standard prostaglandins. concentration or oxygen tension. Hayes et al. (29) noted that cultures of bovine aortic endothelial cells that were maintained in serum-free medium for several days had twice the activitv of cells that were grown in media with 20% fetal calf serum. Leuenberger and associates (41) measured the conversion of angiotensin I to II in the pulmonary vascular beds of dogs and found that hypoxia reduced conversion. Stalcup et al. (42) reported that cultuires of hulman umbilical vein endothelial cells had reduced converting enzyme activity after equilibration with hypoxic gas mixtures. However, since all of the cells in this stuidy were grown under identical conditions, it is unlikely that chaniges in serum or oxygen can account for differences in enzymatic activities between arterial and venous cells. Probably the differences reflect the specializationi of the vessels of origin and indicate that the cuiltured cells remain highly differentiated. Pulmonary endothelial cells appear to be no mnore active than other endothelial cells in metabolizing bradykinin and angiotensin. Although the lung is assumed to be a major site for conversion of angiotensin I (11), only 20-40% of injected angiotensin I is converted during pulmonary passage in normal human subjects (9, 43) . The remainder is converted in extrapulmonary beds. Angiotensin II is more readily inactivated in peripheral circulation than in the pulmonary circulation (9-11), thus there appear to be regionial differences in the metabolism of vasoactive peptides in vivo. Whereas these differences were not apparent in the cultures of cells from different parts of the body, the greater enzymatic activity associated with cells from arteries may reflect one means of controlling methacin inhibits cyclooxygenase, which forms endoperoxides from arachidonic acid (44) . Pulmonary endothelial cells treated with indomethacin could still generate inhibitory activity if they were supplied with PGH2, but cells treated with tranylcypromine could not. Since Marcus and associates (45) showed that cultured endothelial cells can convert PGH2 to prostacyclin via prostacyclin synthetase, it seemns likely that the inhibitory material formed by pulmonary endothelial cells is prostacyclin.
The inhibitory material is formed within 2-5 min after endothelial cell monolayers are stimulated by agitation or scraping. This time-course is similar to that reported for prostacyclin production of fibroblasts and smooth muscle cells (46) and umbilical vein endothelial cells (31) (32) (33) . The ability to inhibit platelet aggregation is lost, however, if the samples are acidified or heated to 100°C. Prostacyclin is similarly labile under these conditions (44 Others found differences in arterial and venous vessels with respect to their ability to form prostacyclin and 6-keto PGFI,a. Skidgel and Printz (47) used a radiolabeled endoperoxide to measure prostacyclin formation in homogenates of vessels from rats. They found that whereas all of the vessels that they examined could metabolize PGH2 to 6-keto PGFI,a, arteries had consistently more activity than veins.
Several conclusions can be drawn from this study of cultured endothelial cells. First, endothelial cells from all the different human vessels studied contain two markers associated with endothelium in vivo, Factor VIII antigen and angiotensin I converting enzyme. Second, retention of these markers by passaged cells indicates that the cells remain differentiated for at least five passages in culture. Finally, cultured endothelial cells, like endothelium in vivo, can metabolize vasoactive peptides and form prostacyclin. These functions appear to be influenced by the vascular origin of the cultured cells.
